The cervical screening program was established to identify increased risk of cervical cancer in women aged between 30 and 60 years. Cervical cancer is caused by a long-term virus infection: the human papillomavirus (HPV). Early detection of HPV can prevent cervical cancer. The Biobank BVO contains left-over cytological material from the cervical screening program. The ambition of the BVO Biobank is to make this residual material available for scientific research to optimize the current cervical cancer screening program. Moreover, it aims to create a more personalized intervention by promoting better understanding of the oncogenic progression and transformation of high-risk HPV (hrHPV) infected cells and the identification/testing of biomarkers or biomarker profiles.
-
Want to know more about these subjects? Click on the buttons below for more news.
Related news items
National Biobanks & Collections day
19 October 2023The Health-RI Biobanks & Collections workgroup proudly announces the first National Biobanks & Collections Day. The meeting will take place on November 9 in Amsterdam.
read moreQuality certificate for the PBMC isolation method and cfDNA extraction method
8 August 2023Last year the Radboud Biobank participated for the first time in the IBBL Biospecimen Proficiency Testing program; an external quality assessment tool to verify the precision and accuracy of biospecimen testing methods and the efficiency of processing methods.
read moreTETRO-trial
30 March 2023The TETRO-trial is a study on a new treatment for compulsive/obsessive-compulsive disorder.
read moreArchipelago
30 March 2023Archipelago of Ovarian Cancer Research (AOCR) is a national platform for centralizing and expanding scientific research into ovarian cancer.
read moreTheme Biobank and collections of Health RI launched a new project to develop a novel Dutch Biobank Standard
30 March 2023In February 2023 the theme Biobanks and Collections of Health-RI launched a new project entitled: “Dutch biobanking standard: towards harmonized, evidence-based collection, processing and storage of human biomaterials”.
read moreHealth-RI receives definitive follow-up funding from the National Growth Fund
30 March 2023The full funding of a total of 69 million euros has been definitively awarded to Health-RI, the national health data infrastructure for research and innovation.
read more